HMGB1 is significantly elevated in SLE patients with purported pro-inflammatory roles; therefore, the ability of soluble CD52 to sequester HMGB1 is potentially another autoregulatory function in SLE patients (57). Here, HMGB1 is linked to systemic lupus erythematosus.